Blood pressure lowering effects of micronutrients in type 2 diabetic patients

Iranian Journal of Endocrinology and Metabolism

Volumn 12, Issue 1, 2010, Pages

  Farvid, M ^a   Homayoni, F ^a   Neyestani, T ^a   Amiri, Z ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Blood pressure; Magnesium; Type 2 diabetes; Vitamin b group; Vitamin c; Vitamin e; Zinc

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; FOLIC ACID; GLUCOSE; GLUCOSE OXIDASE; HEMOGLOBIN A1C; MAGNESIUM; MALONALDEHYDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TRACE ELEMENT; VITAMIN B GROUP; ZINC;

ADULT; AGED; ARTICLE; CHEMICAL ANALYSIS; CLINICAL TRIAL; COLORIMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ZINC BLOOD LEVEL;

EID: 77953502571     PISSN: 16834844     EISSN: 16835476     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Anderson J.W. Diabetes mellitus: Medical Nutrition Therapy. In: Shike M , Ross A.C, Caballero B, Cousing R.J (eds). Modern Nutrition In Health and Disease. 10th ed. Philadelphia: Lipincott Williams & Wilkins, 2005: 1043.
2. Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran. National survey of risk factors for non-communicable diseases of Iran. Diabetes Care 2008; 31: 96-8.
3. Geiss LS, Rolka DB, Engelgau MM: Elevated blood pressure among U.S. adults with diabetes 1988-1994. Am J Prev Med 2002; 22: 42-8.
4. Epstein M. Diabetes and hypertension: the bad companions. J Hypertens 1997; 15 Suppl 1: S55-62.
5. Zozaya JL: Nutritional factors in high blood pressure. J Hum Hypertens 2000; 14 Suppl 1: S100-4.
6. Bonnefont-Rousselot D. The role of antioxidant micronutrients in the prevention of diabetic complications. Treat Endocrinol 2004; 3: 41-52.
7. Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 2005; 59: 365-73.
8. Farvid MS, Siassi F, Jallali M, Hosseini M, Saadat N. The Impact of Vitamin and/or Mineral Supplementation on Blood Pressure in Type 2 Diabetes. J Am Coll Nutr 2004; 23: 272-9.
9. Havivi E, Bar On H, Reshef A, Stein P, Raz I. Vitamins and trace metals status in noninsulin -dependent diabetes mellitus. International Journal of Vitamin and Nutr Res 1991; 61: 328-33.
10. Hermann LS. Metformin: a review of its pharmacological properties and therapeutic use. Diabete metab 1979; 5: 233-45.
11. Arora S, Lidor A, Abularrage CJ, Weiswasser JM, Nylen E. Thiamine (vitamin B1 ) improves endothelium-dependent vasodilation in the presence of hyperglycemia. Ann Vasc Surg 2006; 31: 653-8.
12. Tanaka T, Sohmiya K, Kono T, Terasaki F, Horie R, Ohkaru Y, et al. Thiamine attenuates the hypertension and metabolic abnormalities in CD36-defective SHR: uncoupling of glucose oxidation from cellular entry accompanied with enhanced protein O-GlcNAcylation in CD36 deficiency. Mol Cell Biochem 2007; 299: 23-35. (Pubitemid 46767535)
13. Morrison EY, Ragoobirsingh D, Peter S A. The Unitarian hypothesis for the aetiology of diabetes mellitus. Med Hypotheses 2006; 67: 1115-20.
14. Watanabe-Kamiyama M, Kamiyama S, Horiuchi K, Ohinata K, Shirakawa H, Furukawa Y, et al. Antihypertensive effect of biotin in stroke-prone spontaneously hypertensive rats. Br J Nutr 2008; 99: 756-63.
15. Metz TO, Alderson NL, Thorpe SR, Baynes JW. Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complication. Arch Biochem Biophys 2003; 419: 41-9.
16. Stitt A, Gardiner TA, Anderson NL, Canning P, Frizzel N. The AGE Inhibitor Pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 2002; 51: 2826-32.
17. Van Dijk RA, Rauwerda JA, Steyn M, Twisk JW, Stehouwer CD. Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol 2001;21: 2072-9.
18. Solini A, Santini F, Ferronini E. Effect of Short- term folic acid supplementation on insulin sensitivity and inflammatory markers in over-weight subjects. Int J Obes 2006; 30: 1197-202.
19. McMahon JA, Skeaff CM, Williams SM, Green TJ.Lowering homocysteine with B vitamins has no effect on blood pressure in older adults. J Nutr 2007;137: 1183-7.
20. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, et al .Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004; 291: 565-75.
21. Carr AC, Zhu BZ, Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alphatocopherol (vitamin E). Circ Res 2000; 87: 349-54.
22. Hamilton IM, Gilmore WS, Benzie IF, Mulholland CW, Strain JJ. Interactions between vitamin C and E in human subjects. Br J Nutr 2000; 84: 261-7.
23. Paolisso G, Tagliamonte MR, Barbieri M, Zito GA, Gambardella A, Varricchio G, et al. Chronic vitamin E administration improves brachial reactivity and increases intracellular magnesium concentration in type 2 diabetic patients. J Clin Endocrinol Metab 2000; 85: 109-115. (Pubitemid 32268799)
24. Barbagallo M, Dominguez LJ, Tagliamonte MR, Resnick LM, Paolisso G. Effects of vitamin E and glutathione on glucose metabolism, role of magnesium. Hypertens 1999; 34(4 Pt2): 1002-6.
25. Zago MP, Oteiza PI. The antioxidant properties of zinc: interactions with iron and antioxidants. Free Radic Biol Med 2001; 31: 266-274. (Pubitemid 32607594)
26. Meydani SN, Meydani M, Rall LC, Morrow F, Blumberg JB. Assessment of the safety of high-dose, short-term supplementation with vitamin E in healthy older adults. Am J Clin Nutr 1994; 60: 704-9.
27. Setola E, Monti Id, Galluccio E, Pallosh A, Fragasso G, Porani R, et al. Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocystein levels and hyperinsulinemia. Eur J Endocrin 2004; 151: 483-9.
28. Satoh K: Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 978; 90: 37-43.
29. Rodrigo R, Prat H, Passalaequa W, Araya J, Guichard C, Bachler J P. Relationship between oxidative stress and essential hypertension. Hyperten Res 2007; 30: 1159-67.
30. +) ATPase activity reduction in high glucose - treated human erythrocytes. Free Radic Biol Med 2001; 30: 232-7.
31. Yoshioka M, Matsushita T, Chuman Y. Inverse association of serum ascorbic acid level and blood pressure or rate of hypertension in male adults aged 30-39 years. Int J Vitam Nutr Res 1984;54: 343-7.
32. Sales CH, Pedrosa F C. Magnesium and diabetes mellitus: Their relation. Clin Nutr 2006; 25: 554-62.
33. Fiorina P, Lanfredini M, Montanari A, Peca MG, Veronelli A, Mello A, et al. Plasma homocysteine are related to arterial blood pressure in type 2 diabetes mellitus. Am J of Hyperten 1998; 11: 1100-17.
34. Peacock JM, Folsom AR, Arnett DK, Eckfeldt JH, Szklo M. Relationship of serum and dietary magnesium to incident hypertension: The Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 1999; 9: 159-65.
35. Rodrigo R, Bachler J P, Araya J, Prat H, Passalaequa W. Relationship between (NA+K)-ATPase activity, lipid peroxidation and Fatty acid Profile in erythrocytes of hypertensive and normotensive subjects. Moll Cell Biochem 2007; 303: 73-81. (Pubitemid 47261303)
36. Jee SH, Miller ER 3rd, Guallar E, Singh VK, Apple LJ, Klag MJ. The effect of magnesium supplementation on blood pressure: A meta-analysis of randomized clinical trials. Am J Hypertens 2002; 15: 691-6.
37. Bleie O, Refsum H, Ueland PM, Vollset SE, Guttormsen AB, Nexo E, et al. Changes in basal and postmethionine load concentrations of total homocysteine and Cystathionine after B vitamin intervention. Am J Clin Nutr 2004; 80: 641-8.
38. Vanuzzo D, Pilotto L, Lombardi, R Lazzerini G, Carluccio M, Diviacco S, et al. Both vitamin B6 and total homocysteine plasma levels predict long-term. atherothrombotic events in healthy subjects. Eur Heart J 2007; 28: 484-91.
39. Child DF, Hudson PR, Jones H, Davies GK, De P, Mukherjee S, , et al. The effect of oral folic acid on glutathione, glycemia and lipid in type 2 diabetes. Diabetes Nutr Metab 2004; 17: 95-102.